§
Synergetic EcosystemsStrategic Financial Analysis for Informed Decisions
healthcare

Pharmaceutical Business Unit Divestiture

Rodrigo Montoya
Rodrigo MontoyaMANAGING PARTNER · MADISON HQ
Former VP at Goldman Sachs · Core Practice: M&A Due Diligence
PUBLISHED: Jan 12, 2025READ TIME: 8 min read

Executive Summary & Client Profile

Client: Fortune 500 Pharmaceutical Company · Industry: Healthcare / Pharmaceuticals

The Operational Challenge

The Strategic Solution

Quantifiable Outcomes

| Metric Indicator | Audited Outcome | | --- | --- | | Transaction Value | $425M enterprise value achieved | | Process Timeline | Closed transaction in 7 months | | Multiple Bidders | 6 qualified bidders participated in auction | | Separation Costs | Came in 15% under budget |

"The complexity of separating this business unit was significant. Synergetic Ecosystems brought order to the process and helped us achieve a valuation that exceeded our expectations. Their attention to detail in the diligence process gave buyers confidence."— Patricia Williams, VP Corporate Development

Pharmaceutical Business Unit Divestiture | Synergetic Ecosystems